1 / 47

Topical Pain Control Medication

Topical Pain Control Medication. Gregory Harochaw Pharmacy Manager Tache Pharmacy Phone 204-233-3469 tache@mts.net. Goals and Objectives. Understand the pharmacokinetics of transdermal delivery Advantages/disadvantages of transdermal route Medications used for some different situations .

bernad
Download Presentation

Topical Pain Control Medication

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Topical Pain Control Medication Gregory Harochaw Pharmacy Manager Tache Pharmacy Phone 204-233-3469 tache@mts.net

  2. Goals and Objectives • Understand the pharmacokinetics of transdermal delivery • Advantages/disadvantages of transdermal route • Medications used for some different situations

  3. Metabolism Cytochromes

  4. Parenteral Routes • Intradermal • Small volumes  0.1ml • Absorption is slow  slow onset of action • Subcutaneous • <2ml volumes • Much more rapid absorption than ID • Intramuscular • 2 – 5ml volumes • More rapid absorption than by SC • Can formulate a delayed response • Intravenous • Small to large volumes • No absorption of drug  directly in vein Sterile Dosage Forms: S. Turco, R. King

  5. Pharmacokinetics for Absorption • IV route  immediate & total access to active drug molecules • IM, SC, ID  require an absorption step • The vascularity of the IM route is greater than the SC route   absorption Sterile Dosage Forms: S. Turco, R. King

  6. SC injections  active drug absorbed by diffusion of drug into the capillary network • The greater the blood flow in the capillary network the greater the absorption of the drug • Epinephrine  vasoconstriction   drug absorption • Heat  blood flow   drug absorption

  7. Stratum Corneum (horny layer) • Compared to “bricks & mortar” • 10-15 layers of flattened cornified cells constitute the bricks • Lipid-rich intercellular matrix constitutes the mortar • form an effective barrier to transdermal water loss & external chemical access • If a drug is to pass through the skin & into general circulation, it must 1st traverse this barrier

  8. Factors for Drug Absorption • Transcutaneous flow of compounds across the stratum corneum is directly proportional to the concentration gradient & therefore can be attributed to passive diffusion • As surface area  & thickness of epidermis , the rate of transdermal flux  • The underlying epidermal layers & the dermis area are an aqueous environment

  9. Factors for Drug Absorption • Highly hydrophilic drugs will absorb poorly through the stratum corneum but better in the aqueous layers of the epidermis • Highly lipophilic drugs will absorb better through the stratum corneum but slowed when they reach the aqueous layers of epidermis

  10. Finding a Suitable Carrier • For compounds used exclusively for the treatment of a skin condition, passive diffusion into the superficial epidermis may be sufficient • Using a vehicle such as Glaxal Base or Vaseline • For a drug to be delivered to the general circulation, the drug/vehicle must maintain affinity for both aqueous and lipid environments to absorb effectively

  11. Site Permeability • Generalized rank order of site permeabilities: • genitals > head/neck > trunk > arm > leg • Preterm infant > term infant > young adult > elderly Klein & collegues,. Transdermal Clonidine Therapy in Elderly Mild Hypertensives; Hypertension Suppl 1985:3;581-584

  12. Vehicles Used1 • PLO – Pluronic Lecithin Organobase • Pluronic  hydrophilic phase • Lecithin Isopropyl Palmitate  lipophilic phase • Mixing Pluronic Gel & Lecithin Isopropyl Palmitate under pressure (with the drug) will form an amphiphilic phase containing drug micelles • Gold standard available most Rx • Provides good penetration into skin • Works well with a variety of lipophilic/hydrophilic agents • Need to rub in well??? • “Greasy” base • The 2 phases can separate under cold conditions

  13. Electronic and Electro Mortar & Pestles The electronic mortar & pestle provide pharmacists with the modern way to compound creams,gels, ointments and suspensions.

  14. Ointment Mill The ointment mill mixes powders, crystals and creams into a smooth, finished product

  15. Bases To Be Used1 • Lipoderm • Creamier base than PLO • Cosmetically more elegant • Less sticky • Less smell • Not as temperature sensitive as PLO • Cold temperatures PLO may separate • Less chance of rash vs PLO • Only compounding pharmacies can make

  16. Bases To Be Used1 • Penetration rates: • Pentravan,VanPen, PLO  5-20mm • PCCA Gel 2058  1-3mm (Intradermal) • PCCA Gel 4038  10-20mm • PCCA Gel 6633  +30mm • Speed Gel  up to 50mm

  17. Sports Medicine • Iontophoresis • Enhance absorption of ions by the use of an electrical current • Anti-inflammatory’s, dexamethasone, lidocaine • Phonophoresis • Uses ultrasound to  transcutaneous drug absorption • NSAID’s, dexamethasone

  18. Reasons for Topical Route Oral route not desirable Mucositis Inability to swallow Nausea/vomiting Obstruction Poor taste of product Dry mouth Can produce a more localized action Also can be used for systemic use GH

  19. Topical Route: Advantages Avoids the GI tract and hepatic first-pass metabolism Reduces systemic side effects Improves compliance Allows ↑ concentration of Rx at site of application Plasma concentrations of <10% compared to oral route Heir, Gary DMD, et al. IJPC 2004; 8:337-343

  20. Topical Route: Drawbacks Variations in the stratum corneum barrier • Delivery dosing may require adjustment • Rate of absorption may vary Rash most common SE May be incumbent when using larger areas Heir, Gary DMD, et al. IJPC 2004; 8:337-343

  21. + + - - Prostaglandins Bradykinin Histamine Leukotrienes Step 1: Peripheral Stimulation & Nociceptor Sensitization Substance P Glutamate Aspartic Acid Nitric Oxide Step 2: Signal Transmission Enkephalins Endorphins Medication Step 3: Pain Perception

  22. NMDA and AMPA Receptors Na+ influx exacerbates the Ca++ influx in absence of Mg++ This results in “wind up” pain, LTP and Allodynia

  23. Drugs That Effect Ion Channels • NMDA-Ca++ channel blockers: • Ketamine, orphenadrine, amantadine,DM, magnesium, haloperidol, nylidrin, methadone • AMPA-Na+ channel blockers: • Anticonvulsants • Gabapentin, carbamazepine • Antiarrythmics: • Lidocaine, mexilitine

  24. Ketamine • Widely used as an anesthetic agent • Given IV, IM, PO, PR, intranasally or spinally (Chia et al., 1998; Gehling and Tryba, 1998; Malinovsky et al., 1996; Mercandante et al., 2000; Walker et al., 2002) • Safety and efficacy of ketamine and analgesic well documented (Malinovsky et al., 1996; Reich & Silvay. 1989; White et al., 1982) • Tx in neuropathic pain (Edie et al., 1994, 1995; Jackson et al., 2001; Kannan et al., 2002; Kjepstad & Borchgrevnik., 1997; Mercandante et al., 1995, 2000; Mercandante & Arcuri, 1998) • Phantom limb pain (Knox et al., 1995) • Post-operative pain and other post-traumatic pain (Dick-Neilsen et al.,1992; Gurmani et al., 1996; Hirlinger & Dick, 1984; Hirlinger & Pfenninger, 1987; Lauretti & Azevedo, 1996; Owen et al., 1987) • Control control pain during dressing changes (Bookwalter, 1994; Humphries et al, 1997; Kulbe, 1998; Pal et al, 1997) • Low doses of ketamine have minimal adverse effects on cardiovascular or respiratory function(Miller et al., 2000)

  25. Ketamine2 REQUIRES A TRIPLICATE

  26. Medications Used in Transdermal Delivery Drugs listed in percentages 1% Solution = 1000mg/100ml OR 10mg/ml Hydromorphone 1% solution 10mg/ml

  27. Medications Used in Transdermal Delivery

  28. Medications Used in Transdermal Delivery

  29. Quirks • Ketamine has highest affinity for NMDA receptors of products given • Amitriptyline has a synergistic effect with ketamine • Fibromyalgia baclofen works well as an add on • Complex regional pain amitriptyline and bretylium • Diclofenac > pruritis than ketoprofen

  30. Arthritic Pain • Diclofenac 2 – 4 % used for years • Pennsaid 1.5% • Add • Amitriptyline 2 – 5%  bone pain • Capsaicin 0.025 – 1%  Substance P blocker • Gabapentin 6 – 10%  Neuropathic pain • Lidocaine 2-10%  Na channel blocker

  31. Sciatica • Gabapentin 6%, Clonidine 0.1%, Diclofenac 2% & Lidocaine 2% • Above mixture + Pentoxyfylline 5% • May prevent sciatica caused by a herniated disc Yabuki et al. Prevention of compartment syndrome in dorsal root ganglia caused by exposure to nucleus pulposus. Spine 2001;26:870-875

  32. Shingles • Ketamine 15%, amitriptyline 2-5%, loperamide 5-10%, lidocaine 2-10% • Topical spray • Ketamine 10%, bupivicaine 0.3-0.75% • Ketamine 4%, morphine sulfate 4% • 2-Deoxy-D-Glucose 2%, Diphenhydramine 2%, Lidocaine 4%

  33. Shingles • Capsaicin 0.025-0.1%  substance P blockade • Speed gel??? • Penetration depth up to 50mm • Tx may take up to 8 weeks to get maximum relief

  34. Sensory Neuropathy“Tingling” Sensation • Gabapentin 6%, loperamide 10% & lidocaine 2% • Amitriptyline 2% • Clonidine 0.1% • Apply to affected areas for 2 – 4 weeks

  35. Treatment of Anal Fissures • Nitroglycerin 0.2% Ointment • Success rates 48-78% in treating anal fissures • NTG metabolized it releases nitric oxide  an inhibitory neurotransmitter for smooth muscle • Given 3 – 5 times daily • Nifedipine 0.2% Ointment • Less side effects than NTG • HA’s, dizziness, lightheadedness hypotension • Ca++ antagonist   O2 demand and mechanical contraction of smooth muscle • One study 95% complete healing rate in 21 days

  36. Myofascial Pain

  37. Topical Magnesium • Magnesium Chloride 10% PLO • Use twice daily • Applied across whole “taught” band • Can cause diarrhea • Magnesium 10%/ Pyridoxine 5% PLO • Pyridoxine   pain thresholds and  serotonin levels

  38. Diabetic Neuropathy • Ketamine 15%, Amitriptyline 2-5%, Clonidine 0.1-0.3%%, Nifedipine 2-10%,  Diclofenac 2-4% • Burning sensation  Alpha Lipoic Acid PO 600-1800mg/day Topically 0.5-3%

  39. Fibromyalgia • Ketoprofen 10%, cyclobenzaprine 3%, lidocaine 5% • Amitriptyline 5%, baclofen 2%, diclofenac 2%, lidocaine 2% • Ketoprofen 10% & baclofen 5%  lidocaine 5%

  40. Base:□ Lipoderm □ PLO □ Speed Gel □ Other (specify)_________________ Check the Ingredient & Strength: Other Strength: □ Ketamine __5% __10% __15% ______% (requires a triplicate Rx with this Rx) □ Gabapentin __6% __8% __10% ______% □ Clonidine __0.1% __0.2% ______% □ Lidocaine __2% __4% __5% __10% ______% □ Loperamide __5% __10% ______% □ Ketoprofen __5% __10% __20% ______% □ Diclofenac __2% __4% __5% ______% □ Carbamazepine __2% __5% __10% ______% □ Baclofen __2% __5% ______% □ Amitriptyline __2% __5% ______% □ Pentoxifylline __5% __10% __15% ______% □ Bretylium __1% __2% ______% □ Nifedipine __2% __5% __10% ______% □ Dextromethorphan __10% □ Guaifenesin __5% __10% □ Menthol __ 0.5% □ Camphor __0.25% Additional Ingredients: _________________ _____% _________________ _____% Directions: Apply _____mL to affected area(s) (specify) ________________________ (frequency) _______________________. Mitte: _______mL Refill x _______

More Related